MPN Total Symptom Score (MPN-SAF TSS)

The Myeloproliferative Neoplasm-Symptom Assessment Form Total Symptom Score (MPN-SAF TSS); is a 10-item instrument designed to monitor the clinically relevant symptoms among patients with MPNs. The tool records the patient’s assessment of the incidence and severity of the symptoms given below.

Fatigue Night sweats
Early satiety Itching
Abdominal discomfort Bone pain
Inactivity Fever
Concentration problems Weight loss

The tool can be used to provide a fast, accurate assessment of symptoms associated with MPNs, track symptoms over time, and guide subsequent management decisions.

How to do it >> You need to select most appropriate level of your symptom by using slider on a scale from 0-10 by using slider button given below for each Q.

Score 0 means - absent/no such issue and Score 10 means worst imaginable/as bad as it can be

All 10 Q must be answered between 0-10

1. Please rate your fatigue on a scale of 0 to 10 by slider.

0

2. Filling up quickly when you eat (Early satiety) on a score of 0-10

0

3. Rate your abdominal discomfort on scale of 0-10

0

4. Please rate of level of Inactivity on a scale of 0-10

0

5. Problems with concentration –compared to prior to my diagnosis of MPN

0

6. How much Night sweats do you have

0

7. Level of Itching (pruritus) you feel

0

8. Rate your Bone pain (diffuse not joint pain or arthritis)

0

9. How many days do you have fever (>100 F) (10 = Almost Daily fever)

0

10. Unintentional weight loss last 6 months (0 - Absent, 10 - Worst imaginable)

0

 

Refresh Page for recalculating the score !

The Myeloproliferative Neoplasm-Symptom Assessment Form Total Symptom Score (MPN-SAF TSS); is a 10-item instrument designed to monitor the clinically relevant symptoms among patients with MPNs. The tool records the patient’s assessment of the incidence and severity of the symptoms given below.

Fatigue Night sweats
Early satiety Itching
Abdominal discomfort Bone pain
Inactivity Fever
Concentration problems Weight loss

The tool can be used to provide a fast, accurate assessment of symptoms associated with MPNs, track symptoms over time, and guide subsequent management decisions.

QOL scores were defined as “clinically deficient” if scores were rated as at least 4 of 10 on a 0-to-10 scoring system.

In addition, MPN-SAF TSS items were designated as “moderate” if symptoms were rated as ≥ 4 of 10 or ≤ 6 of 10 and as “severe” if symptoms were rated as ≥ 7 of 10.

The MPN-SAF TSS has possible range of 0 to 100.

References

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

J Clin Oncol. 2012 Nov 20;30(33):4098-103. doi: 10.1200/JCO.2012.42.3863.